Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT)

CUSIP: 45258J102

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
202,731,676
Total 13F shares
33,769,857
Share change
-4,781,460
Total reported value
$293,475,463
Put/Call ratio
8.9%
Price per share
$8.69
Number of holders
115
Value change
-$50,043,046
Number of buys
64
Number of sells
57

Quarterly Holders Quick Answers

What is CUSIP 45258J102?
CUSIP 45258J102 identifies IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) as of Q3 2021

As of 30 Sep 2021, Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) was held by 115 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 33,769,857 shares. The largest 10 holders included EVENTIDE ASSET MANAGEMENT, LLC, STATE STREET CORP, VANGUARD GROUP INC, BlackRock Inc., Alpine Global Management, LLC, TWO SIGMA INVESTMENTS, LP, EcoR1 Capital, LLC, TWO SIGMA ADVISERS, LP, MORGAN STANLEY, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 115 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.